Melanie Lafanechere and Dafni Katsampa summarise a study on the therapeutic alliance and suicidal experiences in people with psychosis receiving Cognitive Behavioural Suicide Prevention Therapy.
[read the full story...]
Shuichi Suetani and Jon Paul Teo discuss the International Research Program on Psychotic Disorders in Diverse Settings (INTREPID II) study, which investigates the epidemiology of untreated psychoses in 3 diverse settings in the Global South.
[read the full story...]
In her debut blog, Jude Madani summarises the findings of the PRODIGY trial, which looked at the clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness.
[read the full story...]
Murtada Alsaif considers a systematic review and meta-analysis published in the Lancet Psychiatry exploring the response of different subgroups of patients with schizophrenia to different antipsychotic drugs.
[read the full story...]
Vishal Aggarwal considers the findings of a recent qualitative study, which looks at the contextual factors, barriers, and facilitators to accessing oral health interventions for people with severe mental illness.
[read the full story...]
In her debut blog, Jodie Ferris summarises a recent cohort study on the temporal relationship between severe mental illness diagnosis and chronic physical comorbidity in the UK, which contains important findings for care and future research.
[read the full story...]
In his debut blog, Kris Deering summarises a paper which looks at the evidence gaps and research priorities for early intervention in psychosis.
[read the full story...]
Silke Vereeken summarises the INTERACT randomised controlled trial, which reports on the efficacy of Acceptance and Commitment Therapy in daily life for people with early psychosis.
[read the full story...]
Ian Kelleher considers a new systematic review of papers from across the world, which looks at the enduring gap in educational attainment for people with schizophrenia.
[read the full story...]
Joe Pierre considers a recent network meta-analysis on continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable.
[read the full story...]
